Drug
olopatadine hydrochloride and mometasone furoate
Marketed as RYALTRIS.
Generic name
olopatadine hydrochloride and mometasone furoate
Brand names
RYALTRIS
First FDA approval
2022-01-13
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA211746 | RYALTRIS | 2022-01-13 | GLENMARK SPECLT |
Manufacturers
GLENMARK SPECLT
Frequently asked questions
When was olopatadine hydrochloride and mometasone furoate FDA approved?
Earliest FDA approval on record: 2022-01-13.
What brand names are sold as olopatadine hydrochloride and mometasone furoate?
RYALTRIS.
Sources
Appeal a olopatadine hydrochloride and mometasone furoate denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com